Pub. Date : 2013 Mar
PMID : 23195915
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Estimation of safe and effective dose of vancomycin in MRSA-infected patients using serum cystatin C concentrations. | Vancomycin | cystatin C | Homo sapiens |
| 2 | OBJECTIVE: To utilize serum cystatin C (CysC) concentration to identify the daily dosage regimen of vancomycin (Van) for the treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. | Vancomycin | cystatin C | Homo sapiens |
| 3 | OBJECTIVE: To utilize serum cystatin C (CysC) concentration to identify the daily dosage regimen of vancomycin (Van) for the treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. | Vancomycin | cystatin C | Homo sapiens |
| 4 | OBJECTIVE: To utilize serum cystatin C (CysC) concentration to identify the daily dosage regimen of vancomycin (Van) for the treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. | Vancomycin | cystatin C | Homo sapiens |
| 5 | OBJECTIVE: To utilize serum cystatin C (CysC) concentration to identify the daily dosage regimen of vancomycin (Van) for the treatment of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. | Vancomycin | cystatin C | Homo sapiens |
| 6 | CysC can estimate the daily dose of Van, and may improve therapeutic success rates of MRSA-infected patients. | Vancomycin | cystatin C | Homo sapiens |